Skip to content

DOCPHARMA

Active Private limited companyfounded 1999active for 27 yearsTerhulpsesteenweg 6, 1560 HoeilaartKBO/BCE: BE 0465.350.075 subsidiary of

Lifetime

19 annual accounts with figures on one time axis, 27 filings since 2000
peak of €25.1m in 2008
-not published
lowest -€17.7m in 31-12-2009
€581,444▼ 51.8%
peak of €66.1m in 2008
€36.6m▲ 1.6%
€13,685▲ 9.8%
peak of 73.7 FTE in 31-03-2009
-not published
Board3 names since 2008
2 directors and 1 other
Owners5 names in the annual accounts
100%
Documentsfilings and deeds
07-07-202624 days before the deadline
2025financial year
Result from €1.2m to €581,444 resigns as director 10-12 resigns as director 10-07

Key points

from the 2025 annual accounts

Equity

€36.6m from €66.1m in 2008

Equity fell by 45% in 17 years.

Result

€581,444 ▼ 51.8%
€1.2m2024€581,0002025

The result fell in 2025 from €1.2m to €581,444.

Payment terms

200 days to suppliers
Suppliers
281 to 200

DOCPHARMA pays its suppliers 81 days earlier than in 2024.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 527 companies had the same profile as DOCPHARMA has now. Each dot stands for 2 companies, two years later.

96.2%
were still trading
3.0%
stopped another way
0.8%
went bankrupt
  • Large
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 527 companies, not a prediction for DOCPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 25-06-2025
Director, since 26-11-2025
Auditor,
  • 100%score equity €27.9m (2025) · annual accounts 2025
  • consolidatesannual accounts 2020

Shares in 1 company,

Board & ownership

Recent changes

reappointed as statutory auditor acts as permanent representative · General meeting of 18-06-2026 · Gazette deed
resigns as director appointed as director · General meeting of 25-11-2025 · Gazette deed
resigns as director appointed as director · General meeting of 24-06-2025 · Gazette deed
resigns as director appointed as director · Discharge granted to · General meeting of 28-02-2024 · Gazette deed
All 76 events

Official details

Source: KBO
Status
Active since 05-03-1999Normal situation
Activity
Manufacture of chemicals and chemical productsNACE 2042001and 1 other2 activities on the establishment unitFrom the articles, 7 activities
Establishment unit
2.103.154.9881560 Hoeilaart, since 23-11-1999
Financial year end
31 December
Peppol
Reachable since 20-11-2020
Company details

Annual accounts 2025

€48.2m▲ 2.2%
Filing
Filed on 07-07-2026, 24 days before the end of the filing period
Financials

Insights on DOCPHARMA

DOCPHARMA has existed since 1999. Turnover fell from €18.4m in 2009 to €91,069 in 2012.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DOCPHARMA

What is the company number of DOCPHARMA?
The company number of DOCPHARMA is 0465.350.075. The VAT number is the same number with BE in front: BE 0465.350.075.
Where is DOCPHARMA based?
The registered office is at Terhulpsesteenweg 6, 1560 Hoeilaart.Company details
What does DOCPHARMA do?
According to the KBO register, the main activity of the establishment unit is manufacture of chemicals and chemical products (NACE 2042001). The KBO lists 1 more.
What is the legal form of DOCPHARMA?
DOCPHARMA is a private limited company (BV).
When was DOCPHARMA founded?
DOCPHARMA was founded on 05-03-1999.
Is DOCPHARMA still active?
Yes, DOCPHARMA is an active enterprise in the KBO register.
What is the turnover of DOCPHARMA?
The annual accounts for financial year 2025 state no turnover.Financials
Is DOCPHARMA profitable?
In financial year 2025, DOCPHARMA made a profit of €581,444.
Where can I find the annual accounts of DOCPHARMA?
DOCPHARMA filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2025. DOCPHARMA also filed 4 sets of consolidated accounts for the group.
When are the next annual accounts of DOCPHARMA due?
DOCPHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.